Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
about
Chemistry and biosynthesis of clavulanic acid and other clavamsPharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection.New advances in the use of antimicrobial agents in surgery: intra-abdominal infections.Pharmacokinetics and pharmacodynamics of amoxicillin-sulbactam, a novel aminopenicillin-beta-lactamase inhibitor combination, against Escherichia coliPulmonary penetration of piperacillin and tazobactam in critically ill patients.Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniaeAssessment of biliary excretion of piperacillin-tazobactam in humansPharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens.Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitorComparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobesEfficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess modelTherapy with cefoperazone plus sulbactam against disseminated infection due to cefoperazone-resistant Pseudomonas aeruginosa and Escherichia coli in granulocytopenic miceEmergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant.Antimicrobial prophylaxis for major head and neck surgery in cancer patients: sulbactam-ampicillin versus clindamycin-amikacin.Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymes.Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.Drug repurposing screens and synergistic drug-combinations for infectious diseases.Screening and isolation of antibiotic resistance inhibitors from herb materials IV-resistance inhibitors from Anetheum graveolens and Acorus gramineus.Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli.Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors.Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.Penetration of piperacillin-tazobactam into bronchial secretions after multiple doses to intensive care patients.Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children.Different ratios of the piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum beta-lactamase.Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases.In vitro and in vivo efficacy of YTR-830H and piperacillin combinations versus beta-lactamase-producing bacteria.Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients.Review of piperacillin/tazobactam in the treatment of bacteremic infections and summary of clinical efficacy.Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam.Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
P2860
Q28247865-24378422-AFFF-4F9E-A00F-FB7E545F620FQ33761118-B6474FF2-D4F0-4A24-AD22-BB6C970A8927Q33840063-B1876DEC-F645-498D-AD55-B8588291AB56Q33977006-782649A0-889C-422B-95DB-2950983346F8Q34216623-43391110-96A7-4165-A2BE-3760BA8C97ACQ35136019-ECA4A753-8CB2-4307-945B-8A1401A6A2FFQ35137461-F58D3403-5903-4313-8DD6-7E3F92F532F9Q35139002-97FA1B74-39FE-4046-A853-16334D635AC2Q35343060-8C6CD700-8FA4-4C99-91C2-969468D938BDQ35350158-DC7CCE65-3429-41BF-ADE1-D43ED08F5C79Q35360429-1CE9D97A-7D6A-4322-AFEB-E623832E1861Q35575783-B20B1C17-A63A-4F26-BC5B-E4E9338B8389Q35810773-6DA7D341-E9FD-445B-9EFE-6575601CBB4FQ35819471-AA3C3AA7-B681-4233-A0A4-1C91BA0F3AB7Q35820623-365BF8E3-B64D-4ECE-80AE-6D4810A8D366Q35896975-36E9AC26-5692-423A-A58B-836991FA6ECAQ35900541-86A081C0-0826-427D-B304-A84CBAE09DBAQ36754084-921B7091-B539-420C-8633-1BB32F0C5A37Q36758337-8A67F731-FB4E-495F-87C7-CB2D1A2035D4Q38158092-9B79B66E-0AF2-44FB-9C3B-6C7B43D67D7BQ38528405-FB7176D0-DB12-433A-A923-407556A48D46Q39815796-FC5CFD5C-1044-49F5-BA59-93F07A329DFDQ39817435-B683BD93-8EBC-457B-9502-FEABE6B10566Q39866597-46E4B3DD-060D-41A0-BE35-757D7770E2C6Q39867376-5A6D9F69-FDE4-4C88-A98E-AE5620E0E2F7Q39867395-E3504CF3-0757-4778-A5EC-2B138549FA84Q40284915-7D25DCE1-EF6F-4BA1-89DD-BFD839E03331Q40285545-9906D385-1F97-48CB-BEDC-26B687B1C38DQ44309116-C678075D-B012-4008-9A50-7E88940FEFE9Q44573110-9C580B61-E0F0-40CC-B234-BEBAFE95519DQ54200563-2FB1DB07-06D7-4995-8AF0-A0A1797805D9Q54241539-EBAAD331-E2DC-4EDC-8049-CC39ABB782ECQ54246543-CFE48121-40FA-4179-BA18-510B5FCA5BCE
P2860
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Comparative activities of the ...... aerobic gram-negative bacilli.
@ast
Comparative activities of the ...... aerobic gram-negative bacilli.
@en
type
label
Comparative activities of the ...... aerobic gram-negative bacilli.
@ast
Comparative activities of the ...... aerobic gram-negative bacilli.
@en
prefLabel
Comparative activities of the ...... aerobic gram-negative bacilli.
@ast
Comparative activities of the ...... aerobic gram-negative bacilli.
@en
P2093
P2860
P356
P1476
Comparative activities of the ...... aerobic gram-negative bacilli.
@en
P2093
P2860
P304
P356
10.1128/AAC.29.6.980
P407
P577
1986-06-01T00:00:00Z